Actionnariat et activité des initiés pour BioCardia, Inc. (BCDA): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $1.25 |
| Capitalisation | $19M |
| Bourse | NASDAQ |
| Pays | US |
Bilan (10 ans)
| Année | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Trésorerie | $21.4M | $12.7M | $5.4M | $5.6M | $21.4M | $12.9M | $7.4M | $1.1M | $2.4M | $2.5M |
| Placements à Court Terme | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Créances | $74000 | $95000 | $274000 | $147000 | $232000 | $147000 | $201000 | $63000 | 0 | $20000 |
| Stocks | $135000 | $191000 | $141000 | $4000 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Courants | $21.9M | $13.3M | $6.2M | $6.4M | $22.7M | $13.5M | $7.9M | $1.5M | $2.6M | $2.7M |
| Immobilisations Corporelles | $111000 | $169000 | $145000 | $1.2M | $712000 | $2.1M | $1.8M | $1.4M | $931000 | $510000 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Incorporels | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Totaux | $22.1M | $13.5M | $6.4M | $7.7M | $23.4M | $15.7M | $9.8M | $3.0M | $3.7M | $3.4M |
| Dettes Fournisseurs | $525000 | $902000 | $743000 | $914000 | $746000 | $507000 | $683000 | $890000 | $385000 | $641000 |
| Dette à Court Terme | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Passifs Courants | $1.4M | $2.3M | $2.5M | $4.0M | $4.2M | $3.7M | $3.6M | $3.6M | $2.3M | $2.4M |
| Dette à Long Terme | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Passifs Totaux | $1.5M | $2.4M | $2.6M | $5.3M | $4.2M | $5.3M | $4.9M | $4.6M | $2.9M | $2.5M |
| Réserves | -$60.1M | -$72.5M | -$86.4M | -$101.1M | -$116.1M | -$128.7M | -$140.6M | -$152.2M | -$160.1M | -$168.3M |
| Capitaux Propres | $20.6M | $11.1M | $3.8M | $2.4M | $19.2M | $10.4M | $4.9M | -$1.6M | $837000 | $895000 |
| Dette Totale | 0 | 0 | 0 | $1.1M | $614000 | $1.9M | $1.6M | $1.3M | $951000 | $528000 |
| Dette Nette | -$21.4M | -$12.7M | -$5.4M | -$4.4M | -$20.8M | -$11.0M | -$5.7M | $212000 | -$1.4M | -$2.0M |
| Fonds de Roulement | $20.5M | $11.0M | $3.7M | $2.4M | $18.4M | $9.8M | $4.3M | -$2.1M | $301000 | $300000 |
Santé financière
| Dette / Capitaux propres | 0.59 |
| Ratio de liquidité | 1.12 |
| Piotroski F-Score | 2 |
| Altman Z-Score | -74.97 |
Rentabilité
| Rentabilité des capitaux propres | -919.33% |
| Rentabilité du capital investi | -581.73% |
| Rentabilité des actifs | -241.08% |
| Marge brute | 0.00% |
| Marge opérationnelle | 0.00% |
| Marge nette | 0.00% |
Entreprises liées: ACXP · ADIL · ALZN · APRE · APVO · CELZ · HCWB
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de BCDA: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions